ArticleCell reports. Medicine2026

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

Alex Watterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.